Top Markets
Coin of the day
SD BioSensor, Inc SD BioSensor, Inc

SD BioSensor, Inc

137310
株式のランク #13251
SD BioSensor Inc., a global leader in in-vitro diagnostics, delivers advanced... SD BioSensor Inc., a global leader in in-vitro diagnostics, delivers advanced point-of-care testing solutions from its base in South Korea. The company's diverse product portfolio features the STANDARD Q rapid diagnostic platform, offering quick results for various parameters including COVID-19. For laboratory settings, they provide the STANDARD F, a multi-parametric, random-access fluorescence immunoassay system, and the STANDARD E, an ELISA-based solution ideal for extensive screening programs. Their STANDARD M system brings molecular diagnostics closer to the patient, comprising analyzers, assay menus, qPCR reagents, and nucleic acid extraction kits. Furthermore, the procell Dx range focuses on diagnosing infectious diseases such as tuberculosis and SARS-CoV-2, alongside assessing immune status through interferon-gamma release assays. Blood glucose meters also form part of their offerings. Founded in 2010, SD BioSensor is headquartered in Suwon.
株価
$4.23
時価総額
$506.22M
変化(1日)
-2.86%
変化(1年)
-41.34%
KR
取引 SD BioSensor, Inc (137310)

カテゴリー

SD BioSensor, Inc(137310)の株式分割履歴
SD BioSensor, Inc株(シンボル:137310)は合計で0回の株式分割を実施しました。
最新の株式分割はAug 31, 2026に行われました。
Aug 31, 2026より前に購入された137310株は、現在0137310株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
3 x4
US
3 x20
FR
0 -
JP
6 x20
US
0 -
CH